Pulished Date October, 2018
ID: 430
Share on
Share on

Europe Tumor Ablation Market By Technology (Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices And Other Ablation Devices) By Treatment (Surgical Ablation, Laparoscopic Ablation And Percutaneous Ablation) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis And Other Cancer), And By Region- Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 430
Pages: 139

Europe Tumor Ablation Market was worth USD 0.14 billion in 2018 and estimated to be growing at a CAGR of 11.6%, to reach USD 0.24  million by 2023. Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver.

Rising Prevalence of cancer is proportional to the growth of growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.

Europe Tumor Ablation Market is driven by key factors such as growing geriatric population across the continent, increasing number of people affected with cancer; technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and raising awareness regarding the benefits offered by ablation procedures over the conventional surgical procedures are also some of the factors boosting the growth of the market. However challenges related to ablation procedures and stringent regulatory guidelines and high costs are some of the factors restraining the market growth.

Europe tumor ablation market is segmented by technology, treatment and application. By technology the market is further sub-segmented into Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating technology segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body. Based on treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. Based on application Europe tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.

On the basis of geography Europe Tumor Ablation market is segmented into United Kingdom, France, Spain, Italy and Germany. Europe is the second largest market for tumor ablation devices owing to rising prevalence of cancer. Within Europe, United Kindgom is the largest market accounting for a share of approximately XX%.

Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Technology                                           

                                5.1.1 Radiofrequency Ablation Devices                 

                                5.1.2 Microwave Ablation Devices                           

                                5.1.3 Cryoablation Devices                          

                                5.1.4 Other Ablation Devices                      

                5.2 By Treatment                                            

                                5.2.1 Surgical Ablation                   

                                5.2.2 Laparoscopic Ablation                        

                                5.2.3 Percutaneous Ablation                      

                5.3 By Application                                           

                                5.3.1 Liver Cancer                            

                                5.3.2 Breast Cancer                        

                                5.3.3 Lung Cancer                            

                                5.3.4 Prostrate Metastasis                          

                                5.3.5 Other Cancers                       

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 U.K                 

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Medtronic Plc.                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Angiodynamics                                         

                8.3 Mermaid Medical                                    

                8.4 HealthTronics                                            

                8.5 Galil Medical Inc.                                      

                8.6 EDAP TMS S.A.                                          

                8.7 Boston Scientific Corporation                                             

                8.8 SonaCare Medical                                    

                8.9 Misonix, Inc.                                              

                8.10 Neuwave Medical, Inc.                                       

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Tumor Ablation Market By Region, From 2018-2023 (USD Million)
  2. Europe Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  3. Europe Radiofrequency Ablation Devices Market By Region, From 2018-2023 (USD Million)
  4. Europe Microwave Ablation Devices Market By Region, From 2018-2023 (USD Million)
  5. Europe Cryoablation Devices Market By Region, From 2018-2023 (USD Million)
  6. Europe other Ablation Devices Market By Region, From 2018-2023 (USD Million)
  7. Europe Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  8. Europe Surgical Ablation Market By Region, From 2018-2023 (USD Million)
  9. Europe Laparoscopic Ablation Market By Region, From 2018-2023 (USD Million)
  10. Europe Percutaneous Ablation Market By Region, From 2018-2023 (USD Million)
  11. Europe Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  12. Europe Liver Cancer Market By Region, From 2018-2023 (USD Million)
  13. Europe Breast Cancer Market By Region, From 2018-2023 (USD Million)
  14. Europe Lung Cancer Market By Region, From 2018-2023 (USD Million)
  15. Europe Prostrate Metastasis Market By Region, From 2018-2023 (USD Million)
  16. Europe other cancer Market By Region, From 2018-2023 (USD Million)
  17. U.K Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  18. U.K Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  19. U.K Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  20. Spain Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  21. Spain Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  22. Spain Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  23. Germany Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  24. Germany Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  25. Germany Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  26. Italy Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  27. Italy Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  28. Italy Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  29. France Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  30. France Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  31. France Tumor Ablation Market By Application, From 2018-2023 (USD Million)

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas